Foodtech innovative research boosted with gut and gut-brain axis

Make major scientific breakthroughs in your innovative foodtech research

It has now been proven that the combination of functional foods can contribute to the prevention of risk factors:

 

  • Slow down cellular aging: by fighting free radicals, functional foods control oxidative stress through antioxidants.
  • Strengthen the immune system: functional foods help protect us from pathogen attacks.
  • Improve intestinal functions: both in terms of the balance of the microbiota and immune activity, bioavailability of nutrients, motility of intestinal transit.
  • Reduce cardiovascular risk factors: support the cardiovascular system through the protective and controlling action of cholesterol and triglyceride levels.
CRO for FOODTECH

Challenge your functional assets with the expert on the gut and gut-organ axis!

The market of functional nutrition for humans and animals is rapidly growing driven by healthy nutrition trends and digital applications that guide consumer choices.

Functional foods (containing components classified or not as nutrients) are now becoming part of a normal diet and have been recognized as capable of influencing a wide range of functions involved in the state of well-being and health, or in the reduction of disease risk factors.

GUT AND GUT-ORGAN PRECLINICAL STUDIES BOOST THE DEVELOPMENT OF YOUR MOLECULES

ENTEROSYS IS A CRO ROOTED IN THE GUT TO SUPPORT INNOVATIVE foodtech RESEARCH

We accompany you in your innovation process for the design and the realization of experimental protocols adapted to the development objectives of your product pipeline. Based on our gut-organ expertise, we offer a wide range of tests providing you with new opportunities for differentiation.

Enterosys offers rapid and innovative protocols for the analysis of physiological parameters in real time. Our approaches allow you to save time and costs in the development of your therapeutics to quickly position or reposition your assets. We help researchers to advance science and improve precision health much faster.

OUR KEY SCIENTIFIC FINDINGS ABOUT THE GUT

Glucose is an Enterosyne with deleterious impact of insulin sensitivity

Glucose is an Enterosyne with deleterious impact of insulin sensitivity

Targeting the enteric nervous system that controls gut motility is now considered as an innovative therapeutic way in T2D to limit intestinal glucose absorption and restore the gut‐brain axis to improve insulin sensitivity. So far, little is known about the role of glucose on duodenal contraction in fasted and fed states in normal and diabetic conditions.

Preserve the bioactive factors of breast milk

Preserve the bioactive factors of breast milk

Human breast milk donated to human milk banks is the sole diet for preterm infants when maternal BM is not available. Pasteurization of donated breast milk is an essential step to inactivate pathogens to ensure microbial safety for preterm babies. The study of intestinal motility can be used to optimize pasteurization processes.

Do you have a question about the contribution of gut models to your preclinical studies and innovation portfolio ?

Our team of experts will be delighted to answer all of your questions. We guide you in the design of an optimized protocol to meet your objectives and add value to your molecules with quick and concrete solutions.